Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia.

We investigated the effect and outcome of allogeneic peripheral blood stem cell (PBSC) rescue for aplastic anemia (AA) patients with graft failure after allogeneic bone marrow transplantation (BMT). Seven (28%) of 25 AA patients who received BMT from HLA-identical sibling donors developed late graft...

Full description

Bibliographic Details
Main Authors: Chung, Ik-Joo, Lee, Je-Jung, Park, Moo-Rim, Kook, Hoon, Cho, Sang-Hee, Hwang, Tai-Ju, Kim, Hyeoung-Joon
Format: Online
Language:English
Published: Korean Academy of Medical Sciences 2002
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054912/
id pubmed-3054912
recordtype oai_dc
spelling pubmed-30549122011-03-15 Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia. Chung, Ik-Joo Lee, Je-Jung Park, Moo-Rim Kook, Hoon Cho, Sang-Hee Hwang, Tai-Ju Kim, Hyeoung-Joon Research Article We investigated the effect and outcome of allogeneic peripheral blood stem cell (PBSC) rescue for aplastic anemia (AA) patients with graft failure after allogeneic bone marrow transplantation (BMT). Seven (28%) of 25 AA patients who received BMT from HLA-identical sibling donors developed late graft failure at a median of 7 months (range, 2.0-9.3 months) after transplantation. The patients with graft failure were treated with PBSC collected from the original donor after mobilization with granulocyte-colony stimulating factor (G-CSF). The median boost dose of peripheral blood mononuclear cells was 3.1 x 10(8)/kg (range, 1.4-11.9 x 10(8)/kg). Median times to reach an absolute neutrophil count greater than 0.5 x 10(9)/L and a platelet count greater than 50 x 10(9)/L were 7 days (range, 4-14 days) and 9 days (range, 3-41 days), respectively. There was sustained graft function in 6 of 7 patients, with a median follow-up duration of 3.3 yr (range, 1.0-6.2 yr). Grade-I acute graft-versus-host disease (GVHD) occurred in 2 patients, while extensive chronic GVHD developed in 3 patients. This report shows that G-CSF-mobilized allogeneic PBSC rescue is very effective in achieving complete and sustained engraftment in patients with AA after graft failure. However, more efficacious measures to prevent extensive chronic GVHD remain to be developed. Korean Academy of Medical Sciences 2002-08 /pmc/articles/PMC3054912/ /pubmed/12172040 Text en
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Chung, Ik-Joo
Lee, Je-Jung
Park, Moo-Rim
Kook, Hoon
Cho, Sang-Hee
Hwang, Tai-Ju
Kim, Hyeoung-Joon
spellingShingle Chung, Ik-Joo
Lee, Je-Jung
Park, Moo-Rim
Kook, Hoon
Cho, Sang-Hee
Hwang, Tai-Ju
Kim, Hyeoung-Joon
Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia.
author_facet Chung, Ik-Joo
Lee, Je-Jung
Park, Moo-Rim
Kook, Hoon
Cho, Sang-Hee
Hwang, Tai-Ju
Kim, Hyeoung-Joon
author_sort Chung, Ik-Joo
title Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia.
title_short Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia.
title_full Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia.
title_fullStr Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia.
title_full_unstemmed Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia.
title_sort allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia.
description We investigated the effect and outcome of allogeneic peripheral blood stem cell (PBSC) rescue for aplastic anemia (AA) patients with graft failure after allogeneic bone marrow transplantation (BMT). Seven (28%) of 25 AA patients who received BMT from HLA-identical sibling donors developed late graft failure at a median of 7 months (range, 2.0-9.3 months) after transplantation. The patients with graft failure were treated with PBSC collected from the original donor after mobilization with granulocyte-colony stimulating factor (G-CSF). The median boost dose of peripheral blood mononuclear cells was 3.1 x 10(8)/kg (range, 1.4-11.9 x 10(8)/kg). Median times to reach an absolute neutrophil count greater than 0.5 x 10(9)/L and a platelet count greater than 50 x 10(9)/L were 7 days (range, 4-14 days) and 9 days (range, 3-41 days), respectively. There was sustained graft function in 6 of 7 patients, with a median follow-up duration of 3.3 yr (range, 1.0-6.2 yr). Grade-I acute graft-versus-host disease (GVHD) occurred in 2 patients, while extensive chronic GVHD developed in 3 patients. This report shows that G-CSF-mobilized allogeneic PBSC rescue is very effective in achieving complete and sustained engraftment in patients with AA after graft failure. However, more efficacious measures to prevent extensive chronic GVHD remain to be developed.
publisher Korean Academy of Medical Sciences
publishDate 2002
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054912/
_version_ 1611445001529589760